Works by Holen, Kyle D

Results: 29
    1
    2
    3

    Dose-escalation study of fixed-dose rate gemcitabine combined with capecitabine in advanced solid malignancies.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2009, v. 64, n. 1, p. 45, doi. 10.1007/s00280-008-0844-1
    By:
    • Attia, Steven;
    • Morgan-Meadows, Sherry;
    • Holen, Kyle D.;
    • Bailey, Howard H.;
    • Eickhoff, Jens C.;
    • Schelman, William R.;
    • Traynor, Anne M.;
    • Mulkerin, Daniel L.;
    • Campbell, Toby C.;
    • McFarland, Thomas A.;
    • Huie, Michael S.;
    • Cleary, James F.;
    • Tevaarwerk, Amye J.;
    • Alberti, Dona B.;
    • Wilding, George;
    • Liu, Glenn
    Publication type:
    Article
    4
    5
    6
    7
    8

    Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma.

    Published in:
    Neuro-Oncology, 2018, v. 20, n. 6, p. 838, doi. 10.1093/neuonc/nox202
    By:
    • Gan, Hui K.;
    • Reardon, David A.;
    • Lassman, Andrew B.;
    • Merrell, Ryan;
    • van den Bent, Martin;
    • Butowski, Nicholas;
    • Lwin, Zarnie;
    • Wheeler, Helen;
    • Fichtel, Lisa;
    • Scott, Andrew M.;
    • Gomez, Erica J.;
    • Fischer, JuDee;
    • Mandich, Helen;
    • Hao Xiong;
    • Ho-Jin Lee;
    • Munasinghe, Wijith P.;
    • Roberts-Rapp, Lisa A.;
    • Ansell, Peter J.;
    • Holen, Kyle D.;
    • Kumthekar, Priya
    Publication type:
    Article
    9

    Efficacy and safety results of ABT-414 in combination with radiation and temozolomide in newly diagnosed glioblastoma.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 7, p. 965, doi. 10.1093/neuonc/now257
    By:
    • Reardon, David A.;
    • Lassman, Andrew B.;
    • van den Bent, Martin;
    • Kumthekar, Priya;
    • Merrell, Ryan;
    • Scott, Andrew M.;
    • Fichtel, Lisa;
    • Sulman, Erik P.;
    • Gomez, Erica;
    • Fischer, JuDee;
    • Ho-Jin Lee;
    • Munasinghe, Wijith;
    • Hao Xiong;
    • Mandich, Helen;
    • Roberts-Rapp, Lisa;
    • Ansell, Peter;
    • Holen, Kyle D.;
    • Gan, Hui K.
    Publication type:
    Article
    10

    Efficacy and safety results of depatuxizumab mafodotin (ABT-414) in patients with advanced solid tumors likely to overexpress epidermal growth factor receptor.

    Published in:
    2018
    By:
    • Goss, Glenwood D.;
    • Vokes, Everett E.;
    • Gordon, Michael S.;
    • Gandhi, Leena;
    • Papadopoulos, Kyriakos P.;
    • Rasco, Drew W.;
    • Fischer, JuDee S.;
    • Chu, Katharine L.;
    • Ames, William W.;
    • Mittapalli, Rajendar K.;
    • Lee, Ho‐Jin;
    • Zeng, Jiewei;
    • Roberts‐Rapp, Lisa A.;
    • Loberg, Lise I.;
    • Ansell, Peter J.;
    • Reilly, Edward B.;
    • Ocampo, Christopher J.;
    • Holen, Kyle D.;
    • Tolcher, Anthony W.;
    • Lee, Ho-Jin
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29